Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)
Clinical trial NCT05217667 · TERMINATED
Trial details
- NCT number
- NCT05217667
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2023-05-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.